Project AURIONAI Use-Cases Research & Innovation
Healthcare

Pathology Whole-Slide Imaging

Self-supervised ViT foundation models for pathology.

vision
11named models
651candidates
0deployments
0in Indonesia

Named Models

GoogleMedGemma 1.5 4BGoogleReleasedApr 2026Runs onnot in the notesClassmultimodal LLMMedGemma 1.5 4BUpdate of MedGemma 4B (arXiv 2604.05081, 6 Apr 2026) adding 3D CT and MRI, whole-slide pathology, anatomical localization, longitudinal chest X-ray and document understanding. Reported gains over MedGemma 1 4B: MedQA +5%, EHRQA +22%, WSI macro F1 +47%, 3D MRI +11% (absolute or relative not stated).Commercial use: not stated; Jakarta hosting: unknown; Indonesian support: not statedMahmood Lab, HarvardUNIMahmood Lab, HarvardReleasedMar 2024Runs onnot in the notesClassvisionPathology foundation model from the Mahmood Lab at Harvard, with weights for academic research only. Published in Nature Medicine on 19 Mar 2024.Commercial use: not stated; Jakarta hosting: unknown; Indonesian support: not statedMicrosoft AIProv-GigaPathMicrosoft AI, ProvidenceReleasednot in the notesRuns onnot in the notesClassvisionProv-GigaPathPathology foundation model attributed to Microsoft and Providence; attribution unverified (page not read).Commercial use: not stated; Jakarta hosting: unknown; Indonesian support: not statedPaigeVirchowPaigeReleasedJul 2024Runs onnot in the notesClassvisionPathology whole-slide image foundation model. Published in Nature Medicine on 22 Jul 2024 with pan-cancer specimen-level AUC 0.950.Commercial use: proprietary terms; Jakarta hosting: unknown; Indonesian support: not statedMahmood Lab, HarvardCONCHMahmood Lab, HarvardReleasedJan 2024Runs onnot in the notesClassvisionMahmood Lab vision-language foundation model for computational pathology, trained on histopathology image-caption pairs.Commercial use: not stated; Jakarta hosting: unknown; Indonesian support: not statedMahmood Lab, HarvardTITANMahmood Lab, HarvardReleasedNov 2024Runs onnot in the notesClassvisionTITANMahmood Lab multimodal whole-slide foundation model for pathology.Commercial use: not stated; Jakarta hosting: unknown; Indonesian support: not statedMahmood Lab, HarvardUNI2-hMahmood Lab, HarvardReleasedJan 2025Runs onnot in the notesClassvisionSecond-generation UNI pathology foundation encoder from Mahmood Lab.Commercial use: not stated; Jakarta hosting: unknown; Indonesian support: not statedPaigeVirchow2PaigeReleasedAug 2024Runs onnot in the notesClassvisionVirchow2Paige pathology foundation model trained with mixed magnifications; successor of Virchow.Commercial use: not stated; Jakarta hosting: unknown; Indonesian support: not statedBioptimusH-optimus-0BioptimusReleasedJul 2024Runs onnot in the notesClassvisionPathology foundation vision transformer published by Bioptimus on Hugging Face.Commercial use: allowed; Jakarta hosting: unknown; Indonesian support: not statedHistAIHibouHistAIReleasedJun 2024Runs onnot in the notesClassvisionHibouFamily of pathology foundation vision transformers from HistAI.Commercial use: allowed; Jakarta hosting: unknown; Indonesian support: not statedPaigePrismPaigeReleasedJul 2024Runs onnot in the notesClassmultimodal LLMPrismPathology vision language model that writes reports from whole-slide image embeddings produced by Paige's Virchow encoder; research licence.Commercial use: non-commercial; Jakarta hosting: unknown; Indonesian support: not stated
Where this comes from
Models the research names for this use case. Research, with sources on each model record.

Who Runs It

No deployment is recorded for this use case.

Where this comes from
Documented uses by named organisations. The evidence column says who made the claim.

Candidate Models

Pan-cancer specimen-level detection (Virchow study)

A general benchmark for this model class, not a test on this use case. Specimen-level pan-cancer detection AUC on pathology slides. AUROC. Higher is better.

PaigeVirchowPaige vendor-reported0.95Mahmood Lab, HarvardUNIMahmood Lab, Harvard vendor-reported0.94OwkinPhikonOwkin vendor-reported0.93CTransPath vendor-reported0.91
00.51
UltralyticsYOLO26lUltralytics, visionReleasedJan 2026open weightsruns on edgehas scoreslast 18 monthsUltralyticsYOLO26mUltralytics, visionReleasedJan 2026open weightsruns on edgehas scoreslast 18 monthsUltralyticsYOLO26nUltralytics, visionReleasedJan 2026open weightsruns on edgehas scoreslast 18 monthsUltralyticsYOLO26sUltralytics, visionReleasedJan 2026open weightsruns on edgehas scoreslast 18 monthsUltralyticsYOLO26xUltralytics, visionReleasedJan 2026open weightshas scoreslast 18 monthsRoboflowRF-DETR 2XLRoboflow, visionReleasedNov 2025runs on edgehas scoreslast 18 monthsRoboflowRF-DETR MRoboflow, visionReleasedNov 2025runs on edgehas scoreslast 18 monthsRoboflowRF-DETR NRoboflow, visionReleasedNov 2025runs on edgehas scoreslast 18 monthsRoboflowRF-DETR SRoboflow, visionReleasedNov 2025runs on edgehas scoreslast 18 monthsMetaSAM 3Meta, visionReleasedNov 2025open weightshas scoreslast 18 months

Showing 10 of 651. All models of this class

Where this comes from
Derived, not researched: models in the directory whose class matches a class this use case uses, excluding family records and models shut down or deprecated. Ranked by how many fit facts they meet, then by release date. Each fit fact is read from the model record.

Sources

  1. A foundation model for clinical-grade computational pathology and rare cancers detection - Nature Medicine nature.com https://www.nature.com/articles/s41591-024-03141-0
  2. Towards a general-purpose foundation model for computational pathology - Nature Medicine nature.com https://www.nature.com/articles/s41591-024-02857-3
  3. MedGemma 1.5 Technical Report arxiv.org https://arxiv.org/abs/2604.05081
  4. China Approves More AI Medical Devices, Expands Into Treatment letsdatascience.com https://letsdatascience.com/news/china-approves-more-ai-medical-devices-expands-into-treatmen-75de1963

To cite this page: Project AURION, AI Use-Cases Research & Innovation, "Pathology Whole-Slide Imaging", https://aurion.semai.id/usecases/hc-pathology-wsi/, records of October 2026.